UPLOAD Filing
ADC Therapeutics SA
Date: July 7, 2025 · CIK: 0001771910 · Accession: 0000000000-25-007098
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288437
Letter
Re: ADC Therapeutics SA Registration Statement on Form S-3 Filed June 30, 2025 File No. 333-288437 Dear Ameet Mallik:
July 7, 2025
Ameet Mallik Chief Executive Officer ADC Therapeutics SA Biop le Route de la Corniche 3B 1066 Epalinges Switzerland
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Yasin Keshvargar
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> July 7, 2025 Ameet Mallik Chief Executive Officer ADC Therapeutics SA Biop le Route de la Corniche 3B 1066 Epalinges Switzerland Re: ADC Therapeutics SA Registration Statement on Form S-3 Filed June 30, 2025 File No. 333-288437 Dear Ameet Mallik: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Yasin Keshvargar </TEXT> </DOCUMENT>